Skip to main content
YUHAN CORPORATION logo

YUHAN CORPORATION — Investor Relations & Filings

Ticker · 000100 ISIN · KR7000100008 KO Manufacturing
Open in API
Filings indexed 618 across all filing types
Latest filing 2026-04-30 Regulatory Filings
Country KR South Korea
Listing KO 000100

About YUHAN CORPORATION

http://eng.yuhan.co.kr

Yuhan Corporation, established in 1926, is an integrated healthcare company engaged in the discovery, development, manufacturing, and marketing of pharmaceutical products. Its diverse portfolio encompasses prescription drugs, over-the-counter (OTC) medications, Active Pharmaceutical Ingredients (APIs), and intermediates for various therapeutic areas, including antibiotics and antivirals. The company also produces veterinary drugs and household goods. In addition to its own product lines, Yuhan operates as a Contract Development and Manufacturing Organization (CDMO), offering comprehensive services to the pharmaceutical sector. Through its affiliates, the company is also involved in specialized areas such as nutrient infusion solutions.

Recent filings

Filing Released Lang Actions
영업(잠정)실적(공정공시)
Regulatory Filings
2026-04-30 Korean
기업설명회(IR)개최(안내공시)
Investor Presentation Classification · 1% confidence The document is a notice of an upcoming Investor Relations (IR) presentation by the company, providing date, time, purpose (2026 Q1 results), and link to materials. It is not the full presentation itself but an event announcement for investors. The closest match in our taxonomy is Investor Presentation (IP).
2026-04-29 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 1% confidence The document is titled “임원ㆍ주요주주 특정증권등 소유상황보고서” and provides detailed holdings and transaction information of a company officer’s shares (executive acquisition/disposition, reporting to regulatory bodies). This corresponds to a statutory insider shareholding/dealing report. Hence it falls under Director’s Dealing (insider transactions).
2026-04-28 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 1% confidence The document is a Korean-language '임원ㆍ주요주주 특정증권등 소유상황보고서' (Form 6.1) filed with the Securities and Futures Commission and Korea Exchange. It details the holdings and changes in holdings of company officers (임원) in specific securities, including a transaction (장내매수) by an officer. This is a disclosure of personal share transactions by a company director/executive, which matches the 'Director's Dealing' category (DIRS). It is not merely an announcement of a report (so not RPA) but the report itself.
2026-04-27 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 1% confidence The document is a Korean “임원ㆍ주요주주 특정증권등 소유상황보고서” (Officer and Major Shareholder Specific Securities Ownership Report), detailing an officer’s shareholding and a change in securities holdings (acquisition/disposal) with dates and quantities. This matches the definition of insider share transactions by directors/executives. Therefore, it is classified as Director’s Dealing (DIRS).
2026-04-27 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 1% confidence The document is a regulatory disclosure titled “임원ㆍ주요주주 특정증권등 소유상황보고서,” detailing an executive’s (임원) share ownership and transaction history. It is a mandatory insider (director/executive) shareholding report rather than a general shareholder threshold notification or full annual/interim report. This matches the definition of Director’s Dealing filings (insider share transactions).
2026-04-21 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.